One of the nation’s largest and most respected providers of hospital and healthcare services, Universal Health Services, Inc. has built an impressive record of achievement and performance. Growing steadily since our inception into an esteemed Fortune 500 corporation, our annual revenues during 2022 were approximately $13.4 billion. In 2022, UHS was again recognized as one of the World’s Most Admired Companies by Fortune; ranked #297 on the Fortune 500; and ranked #391 among U.S. companies on Forbes Global 2000 World’s Largest Public Companies.
Our operating philosophy is as effective today as it was upon the Company’s founding in 1979, enabling us to provide compassionate care to our patients and their loved ones. Our strategy includes building or acquiring high quality hospitals in rapidly growing markets, investing in the people and equipment needed to allow each facility to thrive, and becoming the leading healthcare provider in each community we serve.
Headquartered in King of Prussia, PA, UHS has approximately 94,000 employees. As of February 27, 2023, UHS, through its subsidiaries, operated 28 inpatient acute care hospitals, 331 inpatient behavioral health facilities, 39 outpatient facilities and ambulatory care access points, an insurance offering, a physician network and various related services located in 39 U.S. states, Washington, D.C., Puerto Rico and the United Kingdom. It acts as the advisor to Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT). For additional information visit https://uhs.com/.
Mar 2, 2023 at 3:30 PM EST
Universal Health Services at Citi's 2023 Healthcare Services, MedTech, Tools & HCIT Conference
Feb 28, 2023 at 9:00 AM EST
Q4 2022 Universal Health Services Earnings Conference Call
Nov 17, 2022 at 12:00 PM EST
Universal Health Services at Wolfe Research Healthcare Conference
Nov 10, 2022 at 11:00 AM EST
Universal Health Services at Credit Suisse 31st Annual Healthcare Conference
Oct 26, 2022 at 9:00 AM EDT
Q3 2022 Universal Health Services Earnings Conference Call
Data Provided by Refinitiv. Minimum 15 minutes delayed.
Filing by person(s) reporting owned shares of common stock in a public company >5%
An amendment to the SC 13G filing
An amendment to a SC 13D filing
Annual report which provides a comprehensive overview of the company for the past year
Official notification to shareholders of matters to be brought to a vote ("Proxy")
Board and Management
Alan B. MillerChairman of the Board and Chief Executive Officer
Marc D. MillerPresident
Steve G. FiltonExecutive Vice President and Chief Financial Officer
Marvin G. PemberExecutive Vice President and President Acute Care Division
Matt PetersonExecutive Vice President and President Behavioral Health Division
Charles F. BoyleSenior Vice President and Controller
Geraldine Johnson GeckleSenior Vice President, Human Resources
Matthew D. KleinSenior Vice President and General Counsel
Michael S. NelsonSenior Vice President, Strategic Services
Victor J. RadinaSenior Vice President, Corporate Development
Cheryl K. RamaganoSenior Vice President and Treasurer